Intrinsiqs

Is Bioventus Inc. overvalued?

Bioventus Inc. (BVS) looks undervalued — trading about 79% below its fair value.

Undervalued
Current price $14.26 Fair value $25.51
Price
$14.26
Fair value
$25.51
Current P/E
19.0
Normal P/E
34.0
Market cap
$966.1M
Dividend yield
0.0%
Return on equity
28.4%
Sector
Healthcare

See the full interactive analysis →

Fair value compares BVS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.